- Home
- BAH vs ICLR Comparison
BAH vs ICLR Comparison
Compare BAH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAH
- ICLR
- Stock Information
- Founded
- BAH 1914
- ICLR 1990
- Country
- BAH United States
- ICLR Ireland
- Employees
- BAH N/A
- ICLR N/A
- Industry
- BAH Professional Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BAH Consumer Discretionary
- ICLR Health Care
- Exchange
- BAH Nasdaq
- ICLR Nasdaq
- Market Cap
- BAH 12.0B
- ICLR 14.3B
- IPO Year
- BAH 2010
- ICLR 1998
- Fundamental
- Price
- BAH $87.08
- ICLR $157.88
- Analyst Decision
- BAH Hold
- ICLR Buy
- Analyst Count
- BAH 11
- ICLR 15
- Target Price
- BAH $119.20
- ICLR $211.36
- AVG Volume (30 Days)
- BAH 2.7M
- ICLR 989.2K
- Earning Date
- BAH 10-24-2025
- ICLR 10-22-2025
- Dividend Yield
- BAH 2.52%
- ICLR N/A
- EPS Growth
- BAH 3.12
- ICLR N/A
- EPS
- BAH 6.54
- ICLR 7.47
- Revenue
- BAH $11,706,000,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- BAH N/A
- ICLR N/A
- Revenue Next Year
- BAH $2.72
- ICLR $0.89
- P/E Ratio
- BAH $13.37
- ICLR $21.41
- Revenue Growth
- BAH 2.42
- ICLR N/A
- 52 Week Low
- BAH $82.23
- ICLR $125.10
- 52 Week High
- BAH $186.59
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- BAH 38.44
- ICLR 33.43
- Support Level
- BAH $85.03
- ICLR $159.19
- Resistance Level
- BAH $87.72
- ICLR $167.87
- Average True Range (ATR)
- BAH 3.18
- ICLR 8.45
- MACD
- BAH -0.20
- ICLR -2.75
- Stochastic Oscillator
- BAH 24.51
- ICLR 4.93
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.